March 29, 2017
Cytokinetics Announces Start of Second Cohort in Phase 2 Clinical Trial of CK-2127107 in Patients with SMA
Cytokinetics, Inc. today announced that the second cohort of the Phase 2 clinical trial of CK-2127107 in patients with spinal muscular atrophy (SMA), is open to...
March 23, 2017
The Cure SMA Coverage and Payment Policy Project has two distinct but complementary tracks:
- Outreach on behalf of our community. We’re working with public and private insurers, regulators, and other stakeholders, advocating for prompt, comprehensive coverage for SMA...
March 21, 2017
Genentech Roche provided the following community statement with clinical trial updates for SUNFISH (Type 2/3), FIREFISH (Type 1) and JEWELFISH.
Dear SMA community,
At Genentech (A Member of the Roche Group) we are committed to addressing the urgent needs of...